To evaluate the in-vivo safety and efficacy of skin care formulation in terms of improvement in skin Moisturization, Skin Brightening, Even Skin Tone, reduction in Dark Spot and improvement Skin Radiance on healthy female subjects. - NI

SATIYA NUTRACEUTICALS PRIVATE LIMITED0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1)Having refused to give her assent by signing the consent form.
•2)Taking part in another study liable to interfere with this study.
•3)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
•4)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
•5)Having a progressive asthma (either under treatment or last fit in the last 2 years)
•6)Being epileptic
•7)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
•8)Having cutaneous hypersensitivity
•9)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
•10) Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
•11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
•12)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
•13)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted).

发起方

SATIYA NUTRACEUTICALS PRIVATE LIMITED